糖尿病におけるカイロミクロンレムナントの代謝異常

J-STAGE
  • 朴 明俊
    The Third Department of Internal Medicine, Hirosaki University School of Medicine
  • 梁田 敦子
    The Third Department of Internal Medicine, Hirosaki University School of Medicine
  • 小沼 富男
    The Third Department of Internal Medicine, Hirosaki University School of Medicine
  • 筒井 理裕
    The Third Department of Internal Medicine, Hirosaki University School of Medicine
  • 落合 滋
    The Third Department of Internal Medicine, Hirosaki University School of Medicine
  • 武部 和夫
    The Third Department of Internal Medicine, Hirosaki University School of Medicine

書誌事項

タイトル別名
  • Abnormalities of Chylomicron Remnant Metabolism in Diabetics

抄録

It is well recognized that chylomicron remnant is a risk factor for the development of atherosclerosis. We demonstrated in previous study that Chylomicron remnant was abnormaly accumulated in subjects with non-insulin-dependent diabetes mellitus (NIDDM). This study was designed to evaluate if its abnormality of chylomicron remnant was improved by diabetic treatment. Apolipoprotein (apo) B subfractions (apo B-100 and apo B-48) of VLDL and IDL in 19 subjects with NIDDM were analyzed before and after treatment, using SDS-PAGE method described by Kane et al. Apo B-48 ratio (apo B-48/apo B-100) was calculated. Treatment produced a significant decrease in apo B-48 ratio of VLDL from 0.042±0.014 to 0.029±0.016 (p<0.02). Apo B-48 ratio of IDL was significantly reduced from 0.023±0.012 to 0.012±0.011 (p<0.01). Total cholesterol, triglyceride and protein levels of VLDL were slightly reduced, though these changes were not significant. These levels of IDL were also changed in likewise. These results suggest that abnormal accumulation of chylomicron remnant might be improved by treatment in NIDDM.

収録刊行物

  • 動脈硬化

    動脈硬化 16 (1), 59-62, 1988

    Japan Atherosclerosis Society

詳細情報 詳細情報について

問題の指摘

ページトップへ